Anavex Life Sciences Corp (AVXL)

[rocalinda]

My key take aways from the cc:

- There is no doubt that A-273 is at this stage better than anything treating AD.
- Reafirmation that trials for Rett, PK and AD (Ph-2/3) will be the focus for Q1. Hopefully we will have at least 2 of them started in the next couple of months.
- $17M is enough to fund coporate overhead and some of the trials off the ground, but not enough in my opinion to complete the efforts. However, th Dr. sounds very confident that the money is sufficient for the next 2 years so he is definetly counting on additional cash coming from grants or partnerships.
- We will see volatility for the next few days but my belief is that flippers will be moving on and we will start to see more long-term / institutional investors. The potential is too great to not be taken seriously by the market.

GLTALongs